Guanhao Biotech Co.,Ltd.

Equities

300238

CNE100001575

Medical Equipment, Supplies & Distribution

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-05-15 pm EDT			5-day change	1st Jan Change
10.9 ^CNY	-0.64%		-22.03%	-19.62%

Apr. 25	Guanhao Biotech Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Mar. 05	Guanhao Biotech Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Guanhao Biotech Co.,Ltd. Announces Board Changes

March 16, 2020 at 03:33 pm EDT

Guanhao Biotech Co.,Ltd. at its first extraordinary general meeting of 2020 held on 13 March 2020, approved election of non-independent directors were Zhang Yongming, Sun Feng, Liu Yajuan, Zheng Xuebao, Zhao Juhui, and election of independent directors were Huang Jianbai, Liao Wenyi, Han Junmei and election of non-employee supervisors were Tian Dan and Zhao Jianyi.

Latest news about Guanhao Biotech Co.,Ltd.

Guanhao Biotech Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 25	CI
Guanhao Biotech Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 05	CI
Guanhao Biotech Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-24	CI
Guanhao Biotech Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-22	CI
Guanhao Biotech Co.,Ltd. Announces Management Appointments	23-06-26	CI
Guanhao Biotech Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-20	CI
Guanhao Biotech Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-19	CI
Chinese Shares Finish Higher; Guanhao Biotech Rallies 20% on 500 Million Yuan Deal With Largest Shareholders	23-03-23	MT
Guanhao Biotech’s Actual Controllers to Boost Stake to 39% in 500 Million Yuan Deal; Shares Rally 20%	23-03-23	MT
Guanhao Biotech Co.,Ltd. announced that it expects to receive CNY 500 million in funding from Beijing Century Tianfu Venture Capital Center (Limited Partnership), Beijing Tianyou Investment Co., Ltd., Jiangsu Tianyou Jingan Investment Co., Ltd.	23-03-21	CI
Guanhao Biotech Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-27	CI
Guanhao Biotech Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-25	CI
Guanhao Biotech Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-14	CI
Guanhao Biotech Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-14	CI
Guanhao Biotech Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-25	CI
Guanhao Biotech Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-04-09	CI
Guanhao Biotech Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020	21-03-08	CI
Guanhao Biotech Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2020	20-10-26	CI
Wuhan Constant Science & Technology Co., Ltd. cancelled the acquisition of 26.5% stake in Guangzhou Junsun Medical Technology Co Ltd from Guanhao Biotech Co.,Ltd..	20-10-24	CI
Guanhao Biotech Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2020	20-07-20	CI
Guanhao Biotech Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2019	20-04-24	CI
Guanhao Biotech Co.,Ltd. Announces Board Changes	20-03-16	CI
Tibet Xinyi Investment Co., Ltd. cancelled the acquisition of 20% stake in Guangzhou Youvision Biotech Co., Ltd. from Guanhao Biotech Co.,Ltd..	20-01-23	CI
Wuhan Constant Science & Technology Co., Ltd. entered into an agreement to acquire 26.5% stake in Guangzhou Junsun Medical Technology Co Ltd from Guanhao Biotech Co.,Ltd. for CNY 1.	19-10-24	CI
Guanhao Biotech Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2019	19-10-24	CI

Chart Guanhao Biotech Co.,Ltd.

Duration

Period

More charts

Company Profile

Guanhao Biotech Co Ltd is a China-based company principally engaged in the research, development, production and distribution of regeneration medical materials and medical implanted devices. The Company primarily provides biological dura mater patches, chest general surgery department patching membranes (type P) and (type B), asepsis biological wound-surface protection membranes, type B dura matrix, intraocular lens as well as agent products. The Company is also engaged in provision of related technological services. The Company also provides related biotechnology services. The Company mainly conducts its business in the domestic market.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-08-22 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
GUANHAO BIOTECH CO.,LTD.	-19.62%	400M
ABBOTT LABORATORIES	-5.31%	182B
MEDTRONIC PLC	+3.44%	114B
BECTON, DICKINSON AND COMPANY	-3.33%	68.38B
DEXCOM, INC.	+6.16%	52.46B
CENCORA, INC.	+8.01%	44.25B
HOYA CORPORATION	+7.52%	43.55B
METTLER-TOLEDO INTERNATIONAL, INC.	+25.08%	32.69B
TERUMO CORPORATION	+17.85%	26.73B
WEST PHARMACEUTICAL SERVICES, INC.	-0.40%	25.79B

Other Medical Equipment, Supplies & Distribution